Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
GlobeNewswire
MIAMI, FL, May 01, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on..
MIAMI, FL, May 01, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on..
*Evexta Bio Reports Progress towards Clinical Development of Rupitasertib in Advanced Breast Cancer *
· *Feedback from..
Real-world data demonstrate non-classical mutations are present in 20-30% of all patients with EGFRm NSCLCEmerging data show..